Upcoming events – Novartis’s asthma Zeal and Alnylam's lumasiran test

Upcoming events – Novartis’s asthma Zeal and Alnylam's lumasiran test

Submitted by admin on October 19, 2019 - 1:36pm
Source: 
EP Vantage
News Tags: 
Novartis
fevipiprant
severe asthma
Alnylam
lumasiran
Primary Hyperoxaluria
Headline: 
Upcoming events – Novartis’s asthma Zeal and Alnylam's lumasiran test
snippet: 

Novartis hopes to buck the trend with its DP2 inhibitor fevipiprant, while Alnylam looks for enlightenment with lumasiran.

Do Not Allow Advertisers to Use My Personal information